Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) jumped nearly 20% after positive interim results from its aged dog trial. Treated dogs showed better survival and muscle health, with no adverse events reported so far.
IXICO PLC (AIM:IXI) has added £1.5 million in contracted revenue from a Huntington’s disease trial extension. The income will be recognised over three years, as the group builds repeat business with big pharma clients.
Helium One Global Ltd (AIM:HE1) says the Galactica-Pegasus helium plant in Colorado is set to begin integrated operations next week. The company is moving from commissioning into ramp-up, with spot sales agreed and contract talks ongoing.
Bellevue Healthcare Trust PLC (LSE:BBH) wants Columbia Threadneedle to take over as investment manager. Shareholders are being offered a full exit option at a 2% discount to net asset value.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
